SBIR/STTR Research Award

DNA SEQUENCE CONTEXT AND HYBRIDIZATION REACTION DESIGN

Award identifier b2d2537a485bb877176e97171ef4bc5283d6fa18c2508d706cf1b7bcae9bfd97Awarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$100,000

Program and phase

SBIR · Phase I

Award year

2001

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
DNA CODES, LLC
Proposal award date
Not reported
Contract end date
Not reported
UEI
Not reported
Solicitation number
Not reported
Topic code
Not reported

Research abstract

Hybridization of nucleic acid mixtures to surfaces containing attached complementary nucleic acid moieties (multiplex hybridization) is the principal step in nucleic acid based microarray technologies. Multiplex microarray technologies are increasingly becoming the premiere tool for measuring genome wide gene expression and many diagnostic and prognostic applications in: basic research, drug discovery/development, and assessment of disease susceptibility, therapy strategies, and monitoring. Microarray technology can increase productivity of current low throughput biological assays by hundreds to thousands of times. Such gains hold promise for reducing costs, and broadening availability of such testing to the public. Key benefits arising from this are the possibility for pre-disease treatment protocols. Reliability factors such as high sensitivity and accuracy are major keys to enabling array technology use in all of these scenarios. The proposed research program will test our technology's ability to eliminate the effects of phenomena occurring at the intra and inter molecular level in oligonucleotide DNA microarray hybridizations that: a) reduce sensitivity, precision, accuracy, reproducibility, comparability, and b) increase array density needed, background "noise", assay cost, reliance on "image analysis software interpretations" in any DNA multiplex hybridization based microarray based assay. PROPOSED COMMERCIAL APPLICATIONS: The research will be the first step in developing Chemical standards for designing multiplex DNA Arrays enabling less costly, highest fidelity assays and reliable cross-platform data comparisons. This set of features will be useful in designing unique assays for each "facet" of the health care sector as mentioned above. We believe this broad market can be served because a strategy of licensing of assay chemistries would be pursed. We would stay focused on assay chemistry technology while licensees handle the hardware and software engineering, marketing and system service.

Technology keywords

Not reported

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.